Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 15, 2025Journal of Drug Delivery and TherapeuticsOpen Access

Prevalence of Liver Damage in Patients Under Antiretroviral Therapy at Gitwe District Hospital

View Full Paper
Ask AI
Bookmark
Share

Authors

IPISHIMWE ALAIN PRUDENCETGTharcisse GatembeziGTGratien Twagirumukiza

Discussion

Loading...

Member takes

Overview

Retrospective analysis found 11.32% prevalence of liver damage in HIV patients receiving antiretroviral therapy, suggesting monitoring is essential.

Key Points

  • The study revealed that 11.32% of HIV patients on antiretroviral therapy experienced liver damage.
  • Among 212 patients evaluated, only 4 cases of severe liver damage (1.9%) were documented.
  • The retrospective analysis considered liver function tests for patients on highly active antiretroviral therapy.
  • Regular monitoring for hepatotoxicity among HIV patients may prevent severe liver damage and further complications.

Cite This Study

PRUDENCE et al. (2025) studied this question.

synapsesocial.com/papers/68af76a77567bf4f94feee15https://doi.org/10.22270/jddt.v15i8.7057
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hepatotoxicity of antiretroviral drugs: Risk assessment based on spontaneous reports of adverse reactions2025
  2. 2Liver function impairment and associated factors among adult human immunodeficency virus infected individuals on antiretroviral therapy at Hosanna town, Central Ethiopia2026
  3. 3Hepatic Enzyme Alterations among HIV Positive Individuals on Antiretroviral Therapy in Auchi, Nigeria: A Cross- Sectional Analysis2025
  4. 4Studies on Changes in Some Indices of Liver Function in HIV/AIDS Patients in Highly Active Anti-Retroviral Therapy (HAART) in Imo State, Nigeria2025
  5. 5Assessment of Renal Insufficiency among Patients under Anti-retroviral Therapy at Gitwe District Hospital2025